BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 El-Shawi OE, El-Nashar HAS, Abd El-Rahman SS, Eldahshan OA, Singab ANB. Protective effect of acrocarpus fraxinifolius extract against hepatic fibrosis induced by Gamma irradiation and carbon tetrachloride in albino rats. Int J Radiat Biol 2023;99:270-80. [PMID: 35675546 DOI: 10.1080/09553002.2022.2087926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhao P, Sun T, Lyu C, Liang K, Niu Y, Zhang Y, Cao C, Xiang C, Du Y. Scar-Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis. Adv Sci (Weinh) 2023;10:e2203315. [PMID: 36494102 DOI: 10.1002/advs.202203315] [Reference Citation Analysis]
3 Wong CSM, Mak LLY, Chung HY, Chung MH, Ng LL, Chan SCW, Cheung KS, Yeung CK, Yuen MF, Chan HHL. The role of transient elastography and novel serum biomarkers in assessment of liver fibrosis in patients with psoriasis and rheumatic disease.. [DOI: 10.21203/rs.3.rs-2466990/v1] [Reference Citation Analysis]
4 Guo T, Wantono C, Tan Y, Deng F, Duan T, Liu D. Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease. Front Physiol 2023;14:1098129. [PMID: 36711017 DOI: 10.3389/fphys.2023.1098129] [Reference Citation Analysis]
5 Tsomidis I, Notas G, Xidakis C, Voumvouraki A, Samonakis DN, Koulentaki M, Kouroumalis E. Enzymes of Fibrosis in Chronic Liver Disease. Biomedicines 2022;10. [PMID: 36551935 DOI: 10.3390/biomedicines10123179] [Reference Citation Analysis]
6 Radmanić L, Korać P, Gorenec L, Šimičić P, Bodulić K, Vince A, Lepej SŽ. Distinct Expression Patterns of Genes Coding for Biological Response Modifiers Involved in Inflammatory Responses and Development of Fibrosis in Chronic Hepatitis C: Upregulation of SMAD-6 and MMP-8 and Downregulation of CAV-1, CTGF, CEBPB, PLG, TIMP-3, MMP-1, ITGA-1, ITGA-2 and LOX. Medicina (Kaunas) 2022;58. [PMID: 36556936 DOI: 10.3390/medicina58121734] [Reference Citation Analysis]
7 Zdanowicz K, Kowalczuk-Kryston M, Olanski W, Werpachowska I, Mielech W, Lebensztejn DM. Increase in Serum MMP-9 and TIMP-1 Concentrations during Alcohol Intoxication in Adolescents-A Preliminary Study. Biomolecules 2022;12. [PMID: 35625637 DOI: 10.3390/biom12050710] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pérez-Is L, Collazos J, de la Fuente B, Morano L, Rivas-Carmenado M, Rodriguez M, Romero-Favela A, Fonseca-González GJ, Melón S, Valle-Garay E, Asensi V. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy. Sci Rep 2022;12:3828. [PMID: 35264591 DOI: 10.1038/s41598-022-07548-y] [Reference Citation Analysis]
9 Yoshino K, Taura K, Iwaisako K, Masano Y, Uemoto Y, Kimura Y, Nam NH, Nishino H, Ikeno Y, Okuda Y, Nishio T, Yamamoto G, Seo S, Uemoto S. Novel mouse model for cholestasis-induced liver fibrosis resolution by cholecystojejunostomy. J Gastroenterol Hepatol 2021;36:2493-500. [PMID: 33448457 DOI: 10.1111/jgh.15406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Moriya K, Nishimura N, Namisaki T, Takaya H, Sawada Y, Kawaratani H, Kaji K, Shimozato N, Sato S, Furukawa M, Douhara A, Akahane T, Mitoro A, Yamao J, Yoshiji H. Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis. J Clin Med 2021;10:2465. [PMID: 34199421 DOI: 10.3390/jcm10112465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Martinez-Castillo M, Hernandez-Barragan A, Flores-Vasconcelos I, Galicia-Moreno M, Rosique-Oramas D, Perez-Hernandez JL, Higuera-De la Tijera F, Montalvo-Jave EE, Torre-Delgadillo A, Cordero-Perez P, Muñoz-Espinosa L, Kershenobich D, Gutierrez-Reyes G. Production and activity of matrix metalloproteinases during liver fibrosis progression of chronic hepatitis C patients. World J Hepatol 2021;13:218-32. [PMID: 33708351 DOI: 10.4254/wjh.v13.i2.218] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
12 Sriphoosanaphan S, Thanapirom K, Kerr SJ, Suksawatamnuay S, Thaimai P, Sittisomwong S, Sonsiri K, Srisoonthorn N, Teeratorn N, Tanpowpong N, Chaopathomkul B, Treeprasertsuk S, Poovorawan Y, Komolmit P. Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial. PeerJ 2021;9:e10709. [PMID: 33614272 DOI: 10.7717/peerj.10709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Latronico T, Larocca M, Milella S, Fasano A, Rossano R, Liuzzi GM. Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation. Inflammopharmacology 2021;29:561-71. [PMID: 33196947 DOI: 10.1007/s10787-020-00772-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
14 Dawood RM, El-meguid MA, Salum GM, El Awady MK. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020;40:472-89. [DOI: 10.1089/jir.2020.0059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
15 Medeiros T, Saraiva GN, Moraes LA, Gomes AC, Lacerda GS, Leite PE, Esberard EB, Andrade TG, Xavier AR, Quírico-Santos T, Rosário NF, Silva AA. Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers-a role for MMP-9/TIMP-1. Dig Liver Dis 2020;52:1170-7. [PMID: 32522433 DOI: 10.1016/j.dld.2020.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
16 Wang L, Sun Y, Luo X, Han H, Yin H, Zhao B, Chen X, Yu Q, Qiu H, Yuan X. Prophylactical Low Dose Whole-Liver Irradiation Inhibited Colorectal Liver Metastasis by Regulating Hepatic Niche in Mice. Onco Targets Ther 2020;13:8451-62. [PMID: 32922035 DOI: 10.2147/OTT.S263858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Zhang B, Lai L, Tan Y, Liang Q, Bai F, Mai W, Huang Q, Ye Y. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways. J Ethnopharmacol 2020;254:112714. [PMID: 32105750 DOI: 10.1016/j.jep.2020.112714] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
18 Park YJ, Kim DM, Jeong MH, Yu JS, So HM, Bang IJ, Kim HR, Kwon SH, Kim KH, Chung KH. (-)-Catechin-7-O-β-d-Apiofuranoside Inhibits Hepatic Stellate Cell Activation by Suppressing the STAT3 Signaling Pathway. Cells 2019;9:E30. [PMID: 31861943 DOI: 10.3390/cells9010030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
19 Chen G, Xia B, Fu Q, Huang X, Wang F, Chen Z, Lv Y. Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis. Int J Biol Sci 2019;15:2509-21. [PMID: 31754325 DOI: 10.7150/ijbs.37500] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
20 Jiménez-Sousa MA, Berenguer J, Fernández-Rodríguez A, Medrano LM, Aldámiz-Echevarria T, Pérez-Latorre L, Díez C, Martín-Vicente M, Gutiérrez-Rivas M, Martínez I, Resino S. Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study. Infect Genet Evol 2019;67:112-20. [PMID: 30336268 DOI: 10.1016/j.meegid.2018.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 León-Flores A, Del Río Estrada PM, Álvarez-García LX, Piten-Isidro E, Reyes-Terán G. Increased levels of soluble co-stimulatory molecule PD-L1 (B7-H1) in the plasma of viraemic HIV-1+ individuals. Immunol Lett 2018;203:70-9. [PMID: 30236481 DOI: 10.1016/j.imlet.2018.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
22 Zhang CH, Zheng L, Gui L, Lin JY, Zhu YM, Deng WS, Luo M. Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats. Clin Res Hepatol Gastroenterol 2018;42:118-25. [PMID: 29031875 DOI: 10.1016/j.clinre.2017.09.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
23 Roeb E. Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol. 2018;68-69:463-473. [PMID: 29289644 DOI: 10.1016/j.matbio.2017.12.012] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 14.2] [Reference Citation Analysis]
24 Zhang C, Tian X, Zhang K, Li GY, Wang HY, Wang JH. Protective effects of Foeniculum vulgare root bark extract against carbon tetrachloride-induced hepatic fibrosis in mice. World J Gastroenterol 2017; 23(31): 5722-5731 [PMID: 28883697 DOI: 10.3748/wjg.v23.i31.5722] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
25 Li L, Liu M, Geng C, Zou Y, Jiao T. ORF3 as a sensitive and specific diagnostic index for hepatitis E. Exp Ther Med 2017;13:2767-70. [PMID: 28587339 DOI: 10.3892/etm.2017.4337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Esposito S. Infectious Diseases: Pathophysiology, Diagnostics and Prevention. Int J Mol Sci 2016;17:E1464. [PMID: 27598145 DOI: 10.3390/ijms17091464] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]